eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Abbott Laboratories Limited
Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire, SL6 4XE, UK
Telephone: +44 (0)1628 773 355
Fax: +44 (0)1628 644 185
WWW: http://www.abbottuk.com
Medical Information e-mail: ukmedinfo@abbott.com
Out of Hours Telephone: +44 (0)1628 774 920

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 15/08/2011
PIL Kaletra 80mg/20mg Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to date of revision
  • Extra statutory information
  • Change to dosage and administration
Updated on 16/11/2010 and displayed until 15/08/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 06/01/2010 and displayed until 16/11/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to MA holder contact details
  • Change of contra-indications
Updated on 24/09/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 25/09/2008 and displayed until 24/09/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 05/12/2007 and displayed until 25/09/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to drug interactions
  • Change to date of revision
Updated on 31/10/2007 and displayed until 05/12/2007
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to date of revision
Updated on 09/08/2007 and displayed until 31/10/2007
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
Updated on 10/04/2007 and displayed until 09/08/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
Updated on 23/01/2007 and displayed until 10/04/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 15/12/2006 and displayed until 23/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to drug interactions
Updated on 07/11/2006 and displayed until 15/12/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 11/03/2005 and displayed until 07/11/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 22/02/2005 and displayed until 11/03/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 21/07/2004 and displayed until 22/02/2005
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/11/2001 and displayed until 21/07/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 25/04/2001 and displayed until 15/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  ritonavir
  lopinavir